Roland De Angelis
About Roland De Angelis
Chief Commercial Officer Roland DeAngelis
Roland DeAngelis serves as the Chief Commercial Officer, bringing extensive experience to his role. Joining the company in 2014 through the acquisition of Sanofi-Genzyme's cell therapy and regenerative medicine business unit, DeAngelis has been pivotal in driving commercial strategies and operations. His leadership oversees the commercialization efforts, ensuring alignment with the company's strategic goals.
Roland DeAngelis' Education and Mechanical Engineering Background
Roland DeAngelis holds a Bachelor of Science degree in Mechanical Engineering and Applied Mechanics from the University of Rhode Island. This educational background laid a solid foundation for his technical expertise and problem-solving skills, which he has applied throughout his varied career in both the medical and defense industries.
Roland DeAngelis' Career in Medical Device Management
Before becoming Chief Commercial Officer, Roland DeAngelis held significant roles in the medical device industry. As a group product manager for Smith & Nephew Endoscopy, he managed the knee arthroscopy and reconstruction product line. His responsibilities included product management, market expansion, and strategic product development. Additionally, DeAngelis worked as a product design engineer at Acufex Microsurgical, where he contributed to the design and development of innovative surgical products.
Roland DeAngelis' Early Career in Defense Engineering
Roland DeAngelis began his career as a systems engineer in the defense industry. He worked with Hughes Aircraft and other defense contractors, gaining valuable experience in systems engineering. His work in this field involved developing and integrating defense systems, ensuring they met stringent performance and reliability standards. This engineering foundation provided him with a strong technical acumen beneficial in his subsequent roles in the medical device industry.